Skip to main content
SpringerLink
Log in

Mitochondria and Cancer

  • Conference paper
  • First Online:
Book cover Oncogenes Meet Metabolism

Part of the book series: Ernst Schering Foundation Symposium Proceedings ((SCHERING FOUND,volume 2007/4))

Abstract

Mitochondria contained in cancer cells exhibit two major alterations. First, they are often relatively resistant to the induction of mitochondrial membrane permeabilization (MMP), which is the rate-limiting step of the intrinsic pathway of apoptosis. The mechanisms of MMP resistance have come under close scrutiny because apoptosis resistance constitutes one of the essential hallmarks of cancer. Second, cancer cell mitochondria often exhibit a reduced oxidative phosphorylation, meaning that ATP is generated through the conversion of glucose to pyruvate and excess pyruvate is then eliminated as the waste product lactate. This glycolytic mode of energy production is even observed in conditions of high oxygen tension and is hence called anaerobic glycolysis. Here, we discuss the molecular mechanisms accounting for inhibition of the mitochondrial apoptosis pathway in neoplasia and discuss possible mechanistic links between MMP resistance and anaerobic glycolysis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Adams JM, Cory S (2007a) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26:1324–1337

    Article  CAS  PubMed  Google Scholar 

  • Adams JM, Cory S (2007b) Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr Opin Immunol 19:488–496

    Article  CAS  PubMed  Google Scholar 

  • Aslan M, Ozben T (2003) Oxidants in receptor tyrosine kinase signal transduction pathways. Antioxid Redox Signal 5:781–788

    Article  CAS  PubMed  Google Scholar 

  • Astuti D, Douglas F, Lennard TW, Aligianis IA, Woodward ER, Evans DG, Eng C, Latif F, Maher ER (2001) Germline SDHD mutation in familial phaeochromocytoma. Lancet 357:1181–1182

    Article  CAS  PubMed  Google Scholar 

  • Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der Mey A, Taschner PE, Rubinstein WS, Myers EN et al (2000) Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287:848–851

    Article  CAS  PubMed  Google Scholar 

  • Belzacq AS, Vieira HL, Verrier F, Vandecasteele G, Cohen I, Prevost MC, Larquet E, Pariselli F, Petit PX, Kahn A et al (2003) Bcl-2 and Bax modulate adenine nucleotide translocase activity. Cancer Res 63:541–546

    CAS  PubMed  Google Scholar 

  • Brandon M, Baldi P, Wallace DC (2006) Mitochondrial mutations in cancer. Oncogene 25:4647–4662

    Article  CAS  PubMed  Google Scholar 

  • Brenner C, Kroemer G (2000) Apoptosis. Mitochondria – the death signal integrators. Science 289:1150–1151

    Article  CAS  PubMed  Google Scholar 

  • Briere JJ, Favier J, Benit P, El Ghouzzi V, Lorenzato A, Rabier D, Di Renzo MF, Gimenez-Roqueplo AP, Rustin P (2005a) Mitochondrial succinate is instrumental for HIF1alpha nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions. Hum Mol Genet 14:3263–3269

    Article  CAS  PubMed  Google Scholar 

  • Briere JJ, Favier J, Ghouzzi VE, Djouadi F, Benit P, Gimenez AP, Rustin P (2005b) Succinate dehydrogenase deficiency in human. Cell Mol Life Sci 62:2117–2314

    Article  Google Scholar 

  • Bustamante E, Pedersen PL (1977) High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase. Proc Natl Acad Sci U S A 74:3735–3739

    Article  CAS  PubMed  Google Scholar 

  • Cepeda V, Fuertes MA, Castilla J, Alonso C, Quevedo C, Perez JM (2007) Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem 7:3–18

    Article  CAS  PubMed  Google Scholar 

  • Costantini P, Jacotot E, Decaudin D, Kroemer G (2000) Mitochondrion as a novel target of anticancer chemotherapy. J Natl Cancer Inst 92:1042–1053

    Article  CAS  PubMed  Google Scholar 

  • Decaudin D, Castedo M, Nemati F, Beurdeley-Thomas A, De Pinieux G, Caron A, Pouillart P, Wijdenes J, Rouillard D, Kroemer G, Poupon MF (2002) Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo. Cancer Res 62:1388–1393

    CAS  PubMed  Google Scholar 

  • Deng J, Carlson N, Takeyama K, Dal Cin P, Shipp M, Letai A (2007) BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents. Cancer Cell 12:171–185

    Article  CAS  PubMed  Google Scholar 

  • Favier J, Briere JJ, Strompf L, Amar L, Filali M, Jeunemaitre X, Rustin P, Gimenez-Roqueplo AP (2005) Hereditary paraganglioma/pheochromocytoma and inherited succinate dehydrogenase deficiency. Horm Res 63:171–179

    CAS  Google Scholar 

  • Fulda S, Debatin KM (2006) Resveratrol modulation of signal transduction in apoptosis and cell survival: a mini-review. Cancer Detect Prev 30:217–223

    Article  CAS  PubMed  Google Scholar 

  • Galluzzi L, Larochette N, Zamzami N, Kroemer G (2006) Mitochondria as therapeutic targets for cancer chemotherapy. Oncogene 25:4812–4830

    Article  CAS  PubMed  Google Scholar 

  • Galluzzi L, Maiuri MC, Vitale I, Zischka H, Castedo M, Zitvogel L, Kroemer G (2007) Cell death modalities: classification and pathophysiological implications. Cell Death Differ 14:1237–1243

    Article  CAS  PubMed  Google Scholar 

  • Geromel V, Kadhom N, Cebalos-Picot I, Ouari O, Polidori A, Munnich A, Rotig A, Rustin P (2001) Superoxide-induced massive apoptosis in cultured skin fibroblasts harboring the neurogenic ataxia retinitis pigmentosa (NARP) mutation in the ATPase-6 gene of the mitochondrial DNA. Hum Mol Genet 10:1221–1228

    Article  CAS  PubMed  Google Scholar 

  • Gimenez-Roqueplo AP, Favier J, Rustin P, Mourad JJ, Plouin PF, Corvol P, Rotig A, Jeunemaitre X (2001) The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am J Hum Genet 69:1186–1197

    Article  CAS  PubMed  Google Scholar 

  • Gordan JD, Simon MC (2007) Hypoxia-inducible factors: central regulators of the tumor phenotype. Curr Opin Genet Dev 17:71–77

    Article  CAS  PubMed  Google Scholar 

  • Hickey MM, Simon MC (2006) Regulation of angiogenesis by hypoxia and hypoxia-inducible factors. Curr Top Dev Biol 76:217–257

    Article  CAS  PubMed  Google Scholar 

  • Jiang X, Wang X (2004) Cytochrome C-mediated apoptosis. Annu Rev Biochem 73:87–106

    Article  CAS  PubMed  Google Scholar 

  • Kaelin WG (2005) Proline hydroxylation and gene expression. Annu Rev Biochem 74:115–128

    Article  CAS  PubMed  Google Scholar 

  • Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132–1136

    Article  CAS  PubMed  Google Scholar 

  • Kroemer G (2006) Mitochondria in cancer. Oncogene 25:4630–4632

    Article  CAS  PubMed  Google Scholar 

  • Kroemer G, Petit P, Zamzami N, Vayssiere JL, Mignotte B (1995) The biochemistry of programmed cell death. FASEB J 9:1277–1287

    CAS  PubMed  Google Scholar 

  • Kroemer G, El-Deiry WS, Golstein P, Peter ME, Vaux D, Vandenabeele P, Zhivotovsky B, Blagosklonny MV, Malorni W, Knight RA et al (2005) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 12 [Suppl 2]:1463–1467

    Google Scholar 

  • Kroemer G, Galluzzi L, Brenner C (2007) Mitochondrial membrane permeabilization in cell death. Physiol Rev 87:99–163

    Article  CAS  PubMed  Google Scholar 

  • Le Bras M, Borgne-Sanchez A, Touat Z, El Dein OS, Deniaud A, Maillier E, Lecellier G, Rebouillat D, Lemaire C, Kroemer G et al (2006) Chemosensitization by knockdown of adenine nucleotide translocase-2. Cancer Res 66:9143–9152

    Article  PubMed  Google Scholar 

  • Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW (2004) Hypoxia-inducible factor (HIF-1) alpha: its protein stability and biological functions. Exp Mol Med 36:1–12

    PubMed  Google Scholar 

  • Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479–489

    Article  CAS  PubMed  Google Scholar 

  • Liu X, Kim CN, Yang J, Jemmerson R, Wang X (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86:147–157

    Article  CAS  PubMed  Google Scholar 

  • Lu YP, Lou YR, Yen P, Newmark HL, Mirochnitchenko OI, Inouye M, Huang MT (1997) Enhanced skin carcinogenesis in transgenic mice with high expression of glutathione peroxidase or both glutathione peroxidase and superoxide dismutase. Cancer Res 57:1468–1474

    CAS  PubMed  Google Scholar 

  • MacKenzie ED, Selak MA, Tennant DA, Payne LJ, Crosby S, Frederiksen CM, Watson DG, Gottlieb E (2007) Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells. Mol Cell Biol 27:3282–3289

    Article  CAS  PubMed  Google Scholar 

  • Niemann S, Muller U (2000) Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 26:268–270

    Article  CAS  PubMed  Google Scholar 

  • Nishikawa M, Hashida M (2006) Inhibition of tumour metastasis by targeted delivery of antioxidant enzymes. Expert Opin Drug Deliv 3:355–369

    Article  CAS  PubMed  Google Scholar 

  • Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, Hajduk PJ et al (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435:677–681

    Article  CAS  PubMed  Google Scholar 

  • Pedersen PL (2007) Warburg, me and hexokinase 2: multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the “Warburg Effect”, i.e., elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr 39:211–222

    CAS  Google Scholar 

  • Piva R, Liu J, Chiarle R, Podda A, Pagano M, Inghirami G (2002) In vivo interference with Skp1 function leads to genetic instability and neoplastic transformation. Mol Cell Biol 22:8375–8387

    Article  CAS  PubMed  Google Scholar 

  • Poncet D, Pauleau AL, Szabadkai G, Vozza A, Scholz SR, Le Bras M, Briere JJ, Jalil A, Le Moigne R, Brenner C et al (2006) Cytopathic effects of the cytomegalovirus-encoded apoptosis inhibitory protein vMIA. J Cell Biol 174:985–996

    Article  CAS  PubMed  Google Scholar 

  • Rustin P (2002) Mitochondria, from cell death to proliferation. Nat Genet 30:352–353

    Article  CAS  PubMed  Google Scholar 

  • Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB, Gottlieb E (2005) Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7:77–85

    Article  CAS  PubMed  Google Scholar 

  • Senoo-Matsuda N, Yasuda K, Tsuda M, Ohkubo T, Yoshimura S, Nakazawa H, Hartman PS, Ishii N (2001) A defect in the cytochrome b large subunit in complex II causes both superoxide anion overproduction and abnormal energy metabolism in Caenorhabditis elegans. J Biol Chem 276:41553–41558

    Article  CAS  PubMed  Google Scholar 

  • Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Geuskens M, Kroemer G (1996) Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 184:1331–1341

    Article  CAS  PubMed  Google Scholar 

  • Susin SA, Zamzami N, Castedo M, Daugas E, Wang HG, Geley S, Fassy F, Reed JC, Kroemer G (1997) The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis. J Exp Med 186:25–37

    Article  CAS  PubMed  Google Scholar 

  • Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M et al (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397:441–446

    Article  CAS  PubMed  Google Scholar 

  • Tomiyama A, Serizawa S, Tachibana K, Sakurada K, Samejima H, Kuchino Y, Kitanaka C (2006) Critical role for mitochondrial oxidative phosphorylation in the activation of tumor suppressors Bax and Bak. J Natl Cancer Inst 98:1462–1473

    Article  CAS  PubMed  Google Scholar 

  • Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, Leigh I, Gorman P, Lamlum H, Rahman S et al (2002) Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30:406–410

    Article  CAS  PubMed  Google Scholar 

  • Tsujimoto Y, Shimizu S (2007) Role of the mitochondrial membrane permeability transition in cell death. Apoptosis 12:835–840

    Article  CAS  PubMed  Google Scholar 

  • Warburg O, Poesener K, Negelein E (1924) Über den Stoffwechsel der Tumoren [On metabolism of tumors]. Biochem Z 152:319–344

    Google Scholar 

  • Warburg O, Wind F, Negelein E (1926) The metabolism of tumors in the body. J Gen Physiol 8:519

    Article  Google Scholar 

  • Welsh SJ, Bellamy WT, Briehl MM, Powis G (2002) The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Cancer Res 62:5089–5095

    CAS  PubMed  Google Scholar 

  • Yagoda N, von Rechenberg M, Zaganjor E, Bauer AJ, Yang WS, Fridman DJ, Wolpaw AJ, Smukste I, Peltier JM, Boniface JJ et al (2007) RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447:864–868

    Article  PubMed  Google Scholar 

  • Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129–1132

    Article  CAS  PubMed  Google Scholar 

  • Yang QH, Xu JN, Xu RK, Pang SF (2007) Antiproliferative effects of melatonin on the growth of rat pituitary prolactin-secreting tumor cells in vitro. J Pineal Res 42:172–179

    Article  CAS  PubMed  Google Scholar 

  • Zamzami N, Kroemer G (2001) The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol 2:67–71

    Article  CAS  PubMed  Google Scholar 

  • Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M, Kroemer G (1996) Mitochondrial control of nuclear apoptosis. J Exp Med 183:1533–1544

    Article  CAS  PubMed  Google Scholar 

  • Zoratti M, Szabo I (1995) The mitochondrial permeability transition. Biochim Biophys Acta 1241:139–176

    PubMed  Google Scholar 

  • Zou H, Henzel WJ, Liu X, Lutschg A, Wang X (1997) Apaf-1, a human protein homologous to C elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405–413

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

G. Kroemer is supported by Ligue Nationale Contre le Cancer (équipe labellisée), the European Union (Active p53, ChemoRes, DeathTrain, TransDeath, RIGHT), Cancéropôle Ile-de-France, Institut National du Cancer, and the Agence Nationale pour la Recherche. P. Rustin is supported by Association Contre les Maladies Mitochondriales et Association Française Contre les Myopathies, Leducq Foundation (CarDiaNet), and the European Union (Eumitocombat).

Author information

Authors and Affiliations

  1. Hopital Robert Debre, INSERM, U676, 75019, Paris, France

    P. Rustin

  2. Institut Gustave Roussy, INSERM, U848, Pavillion de Recherche 1, 39 rue Camille Desmoulins, 94805, Villejuif, France

    G. Kroemer

Authors
  1. P. Rustin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Kroemer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Kroemer .

Editor information

G. Kroemer D. Mumberg H. Keun B. Riefke T. Steger-Hartmann K. Petersen

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Rustin, P., Kroemer, G. (2008). Mitochondria and Cancer. In: Kroemer, G., Mumberg, D., Keun, H., Riefke, B., Steger-Hartmann, ., Petersen, K. (eds) Oncogenes Meet Metabolism. Ernst Schering Foundation Symposium Proceedings, vol 2007/4. Springer, Berlin, Heidelberg. https://doi.org/10.1007/2789_2008_086

Download citation

  • DOI: https://doi.org/10.1007/2789_2008_086

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-79477-6

  • Online ISBN: 978-3-540-79478-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation